Tri-Mix Injectable Compounded Drug Recalled for Lack of Sterility Assurance
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling Tri-Mix Papaverine/Phentolamine/PGE-1 injectable vials distributed across the United States and Puerto Rico due to lack of assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II sterility assurance failure for an injectable compounded drug. Loss of sterility assurance in parenteral medications poses a risk of serious infections and health complications, meeting the Class II severe designation criteria.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 12 INJ, a prescription injectable drug compounded at their facility located at 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247. The recall affects 13 vials distributed throughout the United States, including Washington, D.C. and Puerto Rico.
The recall was initiated due to lack of assurance of sterility. The affected lot numbers are 07092021:34 (BUD 10/23/2021); 08302021:33 (BUD 02/08/2022); 08162021:08 (BUD 02/08/2022); 08262021:31 (BUD 02/08/2022); and 09152021:63 (BUD 02/08/2022).
Patients who have received this product should consult with their healthcare provider. Healthcare providers and patients are encouraged to report any adverse effects or concerns related to this product to the FDA.
The recalled product
- Product
- TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 12 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Category
- Drug — Compounded Injectable
- Hazard
- sterility-assurance-failure
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot: 07092021:34 BUD: 10/23/2021
- 08302021:33 BUD: 02/08/2022
- 08162021:08 BUD: 02/08/2022
- 08262021:31 BUD: 02/08/2022
- 09152021:63 BUD: 02/08/2022
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27